Novartis AG (NYSE:NVS)

87.52
Delayed Data
As of May 24
 +3.08 / +3.65%
Today’s Change
64.76
Today|||52-Week Range
88.44
+13.87%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$201.2B

Company Description

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following four segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Contact Information

Novartis AG
Lichtstrasse 35
Basel Basel-stadt (basle Town) 4056
P:(161) 324-1111
Investor Relations:
(161) 324-7944

Employees

Shareholders

Other institutional6.03%
Mutual fund holders4.61%
Individual stakeholders--

Top Executives

Vasant NarasimhanChief Executive Officer
Harry Werner KirschChief Financial Officer
John TsaiChief Medical Officer
Klaus MoosmayerChief Ethics Risk & Compliance Officer
David LebwohlSVP & Franchise Global Program Head